Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

NCT04729998 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Rivaroxaban film-coated tablet 20 mg
DRUG: Xarelto® film-coated tablet 20 mg

Sponsor

Pharmtechnology LLC

Collaborators

[object Object]